Hi Dr T @Davisite
I think this article has come up before, but is there any interest/future intent from the company to look into bisantrene pretreatment combinatory therapy with radiation therapy?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496078/
Similarly, have you looked at combining bisantrene with antibodies for tumour selective uptake?
Ann: Bisantrene shows potent anticancer activity in AML models, page-62
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
-0.090(5.06%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.63 | $449.0K | 263.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2300 | $1.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 8176 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |